Lipoprotein(a) levels in hemodialysis patients: relation to glucose intolerance and hemodialysis duration.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Nephron

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000188653PMID 7477660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apolipoprotein (a) levels and atherogenic lipid fractions in relation to the degree of urinary albumin excretion in type 2 diabetes mellitus.

  1994cited by this paper
• Lipoprotein metabolism and renal failure.

  1993cited by this paper
• Increased incidence of coronary disease in people with impaired glucose tolerance: link with increased lipoprotein(a) concentrations?

  1992cited by this paper
• Lipoprotein(a) and atherosclerosis.

  1991cited by this paper
• Alterations of lipoprotein(a) in patients with diabetic nephropathy.

  1990cited by this paper
• The mysteries of lipoprotein(a).

  1989cited by this paper
• Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis.

  1979cited by this paper
• Accelerated atherosclerosis in prolonged maintenance hemodialysis.

  1974cited by this paper

• The renaissance of lipoprotein(a): Brave new world for preventive cardiology?

  2017cites this paper
• Lipoprotein (a): impact by ethnicity and environmental and medical conditions

  2016cites this paper
• Lipids and atherosclerosis

  2004cites this paper
• Hemoglobin A1c levels in non-diabetic patients with end-stage renal disease (ESRD) receiving hemodialysis

  2004cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE CIÊNCIAS MÉDICAS PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS MÉDICAS: NEFROLOGIA

  2003cites this paper
• Section VII. Vascular disease and risk factors.

  2002cites this paper
• Serum Lipoprotein (a) Levels in Chronic Renal Failure and Liver Cirrhosis Patients. Relationship with Atherosclerosis

  2002cites this paper
• Association of kidney function with serum lipoprotein(a) level: the third National Health and Nutrition Examination Survey (1991-1994).

  2002cites this paper
• Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients.

  2000cites this paper
• Hemodialysis Vascular Access Thrombosis and Lipoprotein(A)

  2000cites this paper
• [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].

  1999cites this paper
• [Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice].

  1998cites this paper
• Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a).

  1998cites this paper
• Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease

  1998cites this paper
• LDL‐unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients

  1997cites this paper
• Lipoprotein(a) in health and disease.

  1996cites this paper
• Decrease in lipoprotein(a) after renal transplantation is related to the glucocorticoid dose

  1996cites this paper
• Are the increased Lp(a) levels in hemodialysis patients related to glucose intolerance and hemodialysis duration?

  1996cites this paper
• Lipoprotein metabolism in renal replacement therapy: a review.

  1996cites this paper
• Lipoprotein(a) in renal disease.

  1996cites this paper